etectRx™ Announces New CEO

UF Innovate | The Hub resident company etectRx^®, Inc., a privately-held digital health company, announced the appointment of pharma veteran Valerie Sullivan as its next president and CEO. In late 2019, the company received FDA clearance for its novel ingestible event marker, the ID-Cap™ System. etectRx is in dialogue with pharma companies to help drive commercialization for its novel technology.

Sullivan, who has been serving etectRx in a consulting role since 2019, brings extensive experience in the pharma, digital health and pharma services industries. Prior to joining etectRx, she served as president of InVentiv Patient Access Solutions, a tech-enabled HUB and patient support services company sold to Xerox in 2015. In addition, she served as vice president and general manager of the patient service center at Pear Therapeutics, a program that she envisioned and built from the ground up.

Learn more about etectRx™ Announces New CEO.